Regulated delivery of molecular cargo to invasive tumour-derived microvesicles

Nature Communications

Volumn 6, Issue , 2015, Pages

  Clancy, James W ^a   Sedgwick, Alanna ^a   Rosse, Carine ^b   Muralidharan Chari, Vandhana ^a   Raposo, Graca ^b   Method, Michael ^c   Chavrier, Philippe ^b   D'Souza Schorey, Crislyn ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b INSTITUT CURIE   (France)

^c Northern Indiana Cancer Consortium Michiana Hematology Oncology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; CELLUBREVIN; MATRIX METALLOPROTEINASE 14; SHORT HAIRPIN RNA; SNARE PROTEIN; TETRASPANIN; UNCLASSIFIED DRUG; V SNARE PROTEIN; FLUORESCENT DYE; VAMP3 PROTEIN, HUMAN;

CANCER; DISEASE INCIDENCE; GENE EXPRESSION; INVASIVENESS; MEMBRANE; MOLECULAR ANALYSIS; TUMOR;

ARTICLE; BODY FLUID; CANCER GROWTH; CANCER PATIENT; CELL INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MEMBRANE MICROPARTICLE; OVARY CANCER; PROTEIN DEGRADATION; TUMOR CELL LINE; TUMOR INVASION; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; PROTEIN TRANSPORT; VASCULARIZATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN TRANSPORT; VESICLE-ASSOCIATED MEMBRANE PROTEIN 3;

EID: 84928385615     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7919     Document Type: Article

References (50)

1. D'Souza-Schorey, C. & Clancy, J. W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 26, 1287-1299 (2012).
2. Shifrin, Jr. D. A., Demory Beckler, M., Coffey, R. J. & Tyska, M. J. Extracellular vesicles: communication, coercion, and conditioning. Mol. Biol. Cell 24, 1253-1259 (2013).
3. Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A. & D'souza-Schorey, C. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123, 1603-1611 (2010).
4. Muralidharan-Chari, V. et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr. Biol. 19, 1875-1885 (2009).
5. Di Vizio, D. et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 69, 5601-5609 (2009).
6. Dolo, V. et al. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res. 58, 4468-4474 (1998).
7. Graves, L. E. et al. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 64, 7045-7049 (2004).
8. Baran, J. et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol. Immunother. 59, 841-850 (2010).
9. Bergmann, C. et al. Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression. Head Neck 31, 371-380 (2009).
10. Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C. & Rak, J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl Acad. Sci. USA 106, 3794-3799 (2009).
11. Al-Nedawi, K. et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619-624 (2008).
12. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
13. Koppler, B., Cohen, C., Schlondorff, D. & Mack, M. Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory propertiesof microparticles. Eur. J. Immunol. 36, 648-660 (2006).
14. Muturi, H. T. et al. Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior. PLoS One 8, e74654 (2013).
15. Bebawy, M. et al. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23, 1643-1649 (2009).
16. Jaiswal, R., Luk, F., Dalla, P. V., Grau, G. E. & Bebawy, M. Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS ONE 8, e61515 (2013).
17. Grange, C. et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346-5356 (2011).
18. Proia, P. et al. Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int. J. Mol. Med. 21, 63-67 (2008).
19. Svensson, K. J. et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc. Natl Acad. Sci. USA 108, 13147-13152 (2011).
20. Weigelin, B., Bakker, G. -J. & Friedl, P. Intravital third harmonic generation microscopy of collective melanoma cell invasion: principles of interface guidance and microvesicle dynamics. IntraVital 1, 32-43 (2012).
21. Di Vizio, D. et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am. J. Pathol. 181, 1573-1584 (2012).
22. Bock, J. B., Matern, H. T., Peden, A. A. & Scheller, R. H. A genomic perspective on membrane compartment organization. Nature 409, 839-841 (2001).
23. Chen, Y. A. & Scheller, R. H. SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell. Biol. 2, 98-106 (2001).
24. Jahn, R. & Scheller, R. H. SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell. Biol. 7, 631-643 (2006).
25. Rothman, J. E. Mechanisms of intracellular protein transport. Nature 372, 55-63 (1994).
26. Kean, M. J. et al. VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. J. Cell Sci. 122, 4089-4098 (2009).
27. Miyata, T. et al. Involvement of syntaxin 4 in the transport of membrane-type 1 matrix metalloproteinase to the plasma membrane in human gastric epithelial cells. Biochem. Biophys. Res. Commun. 323, 118-124 (2004).
28. Steffen, A. et al. MT1-MMP-dependent invasion is regulated by TI-VAMP/ VAMP7. Curr. Biol. 18, 926-931 (2008).
29. Bravo-Cordero, J. J. et al. MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J. 26, 1499-1510 (2007).
30. Sahai, E. & Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719 (2003).
31. Friedl, P. & Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009 (2011).
32. Nevo, J. et al. Mammary-derived growth inhibitor (MDGI) interacts with integrin alpha-subunits and suppresses integrin activity and invasion. Oncogene 29, 6452-6463 (2010).
33. Rantala, J. K. et al. SHARPIN is an endogenous inhibitor of beta1-integrin activation. Nat. Cell Biol. 13, 1315-1324 (2011).
34. Lafleur, M. A., Xu, D. & Hemler, M. E. Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis. Mol. Biol. Cell 20, 2030-2040 (2009).
35. Annaert, W. G., Becker, B., Kistner, U., Reth, M. & Jahn, R. Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J. Cell Biol. 139, 1397-1410 (1997).
36. Stojanovic, M., Germain, M., Nguyen, M. & Shore, G. C. BAP31 and its caspase cleavage product regulate cell surface expression of tetraspanins and integrin-mediated cell survival. J. Biol. Chem. 280, 30018-30024 (2005).
37. Hu, C., Hardee, D. & Minnear, F. Membrane fusion by VAMP3 and plasma membrane t-SNAREs. Exp. Cell. Res. 313, 3198-3209 (2007).
38. Remacle, A. G. et al. The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP). J. Cell Sci. 118, 4975-4984 (2005).
39. Zucker, S., Hymowitz, M., Conner, C. E., DiYanni, E. A. & Cao, J. Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. Lab. Invest. 82, 1673-1684 (2002).
40. Sabeh, F., Shimizu-Hirota, R. & Weiss, S. J. Protease-dependent versus - independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 185, 11-19 (2009).
41. Wolf, K. et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J. Cell Biol. 201, 1069-1084 (2013).
42. Wiesner, C., El Azzouzi, K. & Linder, S. A specific subset of RabGTPases controls cell surface exposure of MT1-MMP, extracellular matrix degradation and three-dimensional invasion of macrophages. J. Cell Sci. 126, 2820-2833 (2013).
43. Remacle, A. G. et al. Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth. Cancer Res. 72, 2339-2349 (2012).
44. Sabeh, F. et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781 (2004).
45. Sabeh, F., Li, X. Y., Saunders, T. L., Rowe, R. G. & Weiss, S. J. Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J. Biol. Chem. 284, 23001-23011 (2009).
46. Hotary, K., Li, X. Y., Allen, E., Stevens, S. L. & Weiss, S. J. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 20, 2673-2686 (2006).
47. Hotary, K. B. et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33-45 (2003).
48. Schweitzer, J. K. & D'Souza-Schorey, C. Localization and activation of the ARF6 GTPase during cleavage furrow ingression and cytokinesis. J. Biol. Chem. 277, 27210-27216 (2002).
49. Tague, S., Muralidharan, V. & D'souza-Schorey, C. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. Proc. Natl Acad. Sci. USA 101, 9671 (2004).
50. Park, M., Penick, E. C., Edwards, J. G., Kauer, J. A. & Ehlers, M. D. Recycling endosomes supply AMPA receptors for LTP. Science 305, 1972-1975 (2004).